PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

Pharma Marketing Network

MARCH 25, 2022

But one key member is often omitted: the patient’s caregiver. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. Sunny’s healthcare marketing agency, Xavier Creative House, specializes in pharmaceutical, biotech, and medical device.

Pharma 98

Pharma Education Transportation Training 98

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Weiss has also made substantial efforts to give back to the community at large.

Marketing 52

Marketing Education Media Healthcare 52

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 111

Pharma Food and Drug Administration Recruitment Pharmacology 111

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK’s HIV business, run through joint venture company ViiV Healthcare, also had a good quarter with sales up 14% to £1.4 billion and vaccine firm Affinivax for up to $3.3

Sales 52

Sales Biopharma Prescription Medicine 52

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Director US Marketing and Patient Engagement, argenx US, Inc. Cardiology: Bradley A.

Education 52

Education Marketing Media Biopharma 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. states and the United Kingdom and sees more than 35 million patient encounters per year.

Networking 52

Networking Healthcare Healthcare Competition 52

Clarivate

APRIL 19, 2024

7] FLLs are often found incidentally during imaging for other purposes, such as the assessment of abdominal pain or during surveillance for liver metastases in patients with non-liver cancer. [8] 22] They are also performed in a dedicated room, where the patient is confined to a large scanner on their own and may experience discomfort. [24]

Medical 59

Medical Patients Specialization Healthcare 59

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process. In parallel, the CDE also established a special channel to facilitate these approvals.

Marketing 52

Marketing Patients Management Insurance 52

Pharmaceutical Technology

JUNE 15, 2023

Learn about how AI is helping companies right now, what to know about its benefits and challenges, and what’s needed to implement AI in biopharma research. AI and its healthcare applications will continue to evolve, but you can already realize many potential benefits. How is AI used in the pharmaceutical industry?

Pharma 52

Pharma Management Networking Manufacturing 52

PM360

NOVEMBER 21, 2022

Many of biopharma’s most exciting innovations come from the field of rare and ultra-rare diseases like Marc’s. With the development of new technology platforms at breakneck speed, companies are positioning themselves to one day deliver game-changing solutions to patients in their niche—solutions they may have been waiting for all their life.

Patients 52

Patients Medicine Biopharma Media 52

PM360

JUNE 30, 2022

Now, the two companies will unite their full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services to create a new organization called Inizio. It includes companies Vynamic, Research Partnership, Putnam Associates, and STEM Healthcare.

Specialization 97

Specialization Healthcare Healthcare Consulting 97

Clarivate

MAY 24, 2023

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers. Most patients must use a wheelchair by the time they are in their teens.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

pharmaphorum

JANUARY 11, 2023

The research solutions cluster came second, with 15% of the total (just over $5 billion) – marked by a $300 million third round for Chinese bioinformatics firm Enzymaster – with patient solutions at 11% ($3.6 Roche tops biopharma partnering podium. billion) led by a $300 million Series E for connected kidney care specialist Somatus.

Biopharma 73

Biopharma Specialization Physicians Healthcare 73

European Pharmaceutical Review

OCTOBER 2, 2023

Eligible companies classified as start-ups and active in the pharma, biopharma, digital, or medical device sectors can exhibit. This special edition will introduce three new categories, acknowledging the remarkable wave of innovation that has engulfed the industry. Patient Centric Development , and Quality Management Fundamentals.

Manufacturing 96

Manufacturing Pharma Engineering Networking 96

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero. References: Elverum K, Whitman M.

Manufacturing 74

Manufacturing Pharmaceutical Healthcare Healthcare 74

Medgadget

MARCH 2, 2023

Special software that takes DICOM images from CT scanners and creates a treatment plan, defines the distribution of the Alpha DaRT sources within the tumor. The rest of the patients had partial responses. with ten patients to try to duplicate the results. which are currently recruiting patients.

Manufacturing 83

Manufacturing Leads Patients Medicine 83

Pharmaceutical Technology

APRIL 24, 2023

Because biologics work with live cells, manufacturing them is difficult, and highly specialized facilities and infrastructure are needed. Free Whitepaper Choosing the ‘right’ CRO/CDMO in Biopharma: What has changed? Biopharma outsourcing has rapidly developed.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp.

Marketing 69

Marketing Biopharma Pharma Competition 69